Charles River Laboratories International Inc. (CRL
Post# of 250601
Posted On: 11/21/2014 5:04:40 AM
Charles River Laboratories International Inc. (CRL) Financials Nov 20, 2014, 4:16 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Charles River Laboratories International Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.2B 1.13B 1.14B 1.13B 1.17B
Cost of Goods Sold (COGS) incl. D&A 796.36M 762.2M 761.19M 750.77M 782.75M
COGS excluding D&A 702.8M 668.55M 675.96M 669.49M 686.12M
Depreciation & Amortization Expense 93.55M 93.65M 85.23M 81.28M 96.64M
Depreciation 65.11M 69.24M 63.43M 63.21M 78.83M
Amortization of Intangibles 28.45M 24.41M 21.8M 18.07M 17.81M
Gross Income 406.2M 371.22M 381.46M 378.76M 382.78M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 224.42M 227.56M 182.55M 206.88M 223.95M
Research & Development - - - - -
Other SG&A 224.42M 227.56M 182.55M 206.88M 223.95M
Other Operating Expense 0 0 0 0 0
Unusual Expense 14.85M 442.17M 19.24M 7.38M 7.13M
EBIT after Unusual Expense (14.85M) (442.17M) (19.24M) (7.38M) (7.13M)
Non Operating Income/Expense 2.09M (1.48M) (6.65M) (1.39M) 614,000
Non-Operating Interest Income 1.78M 1.19M 1.35M 589,000 730,000
Equity in Affiliates (Pretax) - 0 869,000 (618,000) 5.86M
Interest Expense 21.68M 35.28M 42.59M 33.34M 20.58M
Gross Interest Expense 24.18M 35.34M 42.59M 33.81M 20.82M
Interest Capitalized 2.5M 56,000 - 467,000 243,000
Pretax Income 149.11M (334.08M) 132.66M 129.75M 138.33M
Income Tax 39.73M 23,000 17.14M 27.63M 32.91M
Income Tax - Current Domestic (2.79M) 13.79M 5.08M (94,000) 15.07M
Income Tax - Current Foreign 26.72M 23.78M 20.73M 26.41M 18.37M
Income Tax - Deferred Domestic 17.45M (27.86M) 2.98M 13.99M 5.9M
Income Tax - Deferred Foreign (1.66M) (9.7M) (11.65M) (12.68M) (6.43M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 109.38M (334.11M) 115.52M 102.12M 105.42M
Minority Interest Expense (1.84M) (5.45M) 411,000 571,000 1.32M
Net Income 111.22M (328.66M) 115.11M 101.55M 104.09M
Extraordinaries & Discontinued Operations 3.22M (8.01M) (5.55M) (4.25M) (1.27M)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 3.22M (8.01M) (5.55M) (4.25M) (1.27M)
Net Income After Extraordinaries 114.44M (336.67M) 109.57M 97.3M 102.83M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 111.22M (328.66M) 115.11M 101.55M 104.09M
EPS (Basic) 1.75 (5.38) 2.16 2.03 2.15
Basic Shares Outstanding 65.37M 62.56M 50.82M 47.91M 47.74M
EPS (Diluted) 1.74 (5.38) 2.14 2.01 2.12
Diluted Shares Outstanding 65.64M 62.56M 51.32M 48.41M 48.49M
EBITDA 275.33M 237.31M 284.14M 253.16M 255.46M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Charles River Laboratories International Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.2B 1.13B 1.14B 1.13B 1.17B
Cost of Goods Sold (COGS) incl. D&A 796.36M 762.2M 761.19M 750.77M 782.75M
COGS excluding D&A 702.8M 668.55M 675.96M 669.49M 686.12M
Depreciation & Amortization Expense 93.55M 93.65M 85.23M 81.28M 96.64M
Depreciation 65.11M 69.24M 63.43M 63.21M 78.83M
Amortization of Intangibles 28.45M 24.41M 21.8M 18.07M 17.81M
Gross Income 406.2M 371.22M 381.46M 378.76M 382.78M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 224.42M 227.56M 182.55M 206.88M 223.95M
Research & Development - - - - -
Other SG&A 224.42M 227.56M 182.55M 206.88M 223.95M
Other Operating Expense 0 0 0 0 0
Unusual Expense 14.85M 442.17M 19.24M 7.38M 7.13M
EBIT after Unusual Expense (14.85M) (442.17M) (19.24M) (7.38M) (7.13M)
Non Operating Income/Expense 2.09M (1.48M) (6.65M) (1.39M) 614,000
Non-Operating Interest Income 1.78M 1.19M 1.35M 589,000 730,000
Equity in Affiliates (Pretax) - 0 869,000 (618,000) 5.86M
Interest Expense 21.68M 35.28M 42.59M 33.34M 20.58M
Gross Interest Expense 24.18M 35.34M 42.59M 33.81M 20.82M
Interest Capitalized 2.5M 56,000 - 467,000 243,000
Pretax Income 149.11M (334.08M) 132.66M 129.75M 138.33M
Income Tax 39.73M 23,000 17.14M 27.63M 32.91M
Income Tax - Current Domestic (2.79M) 13.79M 5.08M (94,000) 15.07M
Income Tax - Current Foreign 26.72M 23.78M 20.73M 26.41M 18.37M
Income Tax - Deferred Domestic 17.45M (27.86M) 2.98M 13.99M 5.9M
Income Tax - Deferred Foreign (1.66M) (9.7M) (11.65M) (12.68M) (6.43M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 109.38M (334.11M) 115.52M 102.12M 105.42M
Minority Interest Expense (1.84M) (5.45M) 411,000 571,000 1.32M
Net Income 111.22M (328.66M) 115.11M 101.55M 104.09M
Extraordinaries & Discontinued Operations 3.22M (8.01M) (5.55M) (4.25M) (1.27M)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 3.22M (8.01M) (5.55M) (4.25M) (1.27M)
Net Income After Extraordinaries 114.44M (336.67M) 109.57M 97.3M 102.83M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 111.22M (328.66M) 115.11M 101.55M 104.09M
EPS (Basic) 1.75 (5.38) 2.16 2.03 2.15
Basic Shares Outstanding 65.37M 62.56M 50.82M 47.91M 47.74M
EPS (Diluted) 1.74 (5.38) 2.14 2.01 2.12
Diluted Shares Outstanding 65.64M 62.56M 51.32M 48.41M 48.49M
EBITDA 275.33M 237.31M 284.14M 253.16M 255.46M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼